Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4)

Immunology

Volumn 90, Issue 2, 1997, Pages 219-228

  Nihrane, A ^a   Silver, J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOMODULATION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE; TRANSGENIC MOUSE; VIRUS ENVELOPE;

EID: 0031026299     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00157.x     Document Type: Article

References (49)

1. FRIEND C. (1957) Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J Exp Med 105, 307.
2. STEEVES R. (1975) Spleen-focus forming virus in Friend and Rauscher leukemia virus preparations. J Natl Cancer Inst 54, 289.
3. r resistance gene. Proc Natl Acad USA 87, 9985.
4. LI J., D'ANDREA A., LODISH H.F. & BALTIMORE D. (1990) Activation of cell growth by binding of Friend Spleen Focus-Forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343, 762.
5. CHESEBRO B., MIYAZAWA M. & BRITT W.J. (1990) Host genetic control of spontaneous and induced immunity to Friend Murine retrovirus infection. Annu Rev Immunol 8, 477.
6. LILLY F. & PINKUS T. (1973) Genetic control of murine leukemogenesis. Adv Cane Res 17, 231.
7. SUZUKI S. (1975) A new gene affecting the splenomegaly induction by Friend leukemia virus. Jpn J Exp Med 15, 473.
8. KAI K., IKEDA H., YUASA Y., SUZUKI S. & ODAKA T. (1976) Mouse strain resistant to N-, B- and NB-tropic murine leukemia viruses. J Virol 20, 436.
9. ODAKA T., IKEDA H., YOSHIKURA H., MORIWAKI K. & SUZUKI S. (1981) Fv-4: gene controlling resistance to NB-tropic Friend murine leukemia virus. Distribution in wild mice, introduction into genetic background of BALB/c, and mapping of chromosomes. J Natl Cancer Inst 67, 1123.
10. IKEDA H., SATO H. & ODAKA T. (1981) Mapping of the Fv4-mouse gene controlling resistance to murine leukemia viruses. Int J Cancer 28, 237.
11. IKEDA H. & ODAKA T. (1983) Cellular expression of murine leukemia virus gp-70-related antigen on thymocytes of uninfected mice correlated with Fv-4 gene-controlled resistance to FV infection. Virology 128, 127.
12. IKEDA H. & ODAKA T. (1984) A cell membrane gp70 associated with Fv-4 gene: immunological characterization and tissue and strain distribution. Virology 133, 65.
13. IKEDA H., LAIGRET F., MARTIN M.A. & REPASKE R. (1985) Characterization of a molecularly cloned retroviral sequence associated with Fv-4 resistance. J Virol 55, 768.
14. IKEDA H. & SUGIMURA H. (1989) Fv-4 resistance gene. A truncated endogenous murine leukemia virus with ecotropic interference properties. J Virol 63, 5405.
15. YOSHIKURA H. & ODAKA T. (1979) Unstable resistance of G mouse fibroblasts to ecotropic murine leukemia virus infection. J Virol 29, 1078.
16. LIMJOCO T.I., DICKIE P., IKEDA H. & SILVER J. (1993) Transgenic Fv-4 mice resistant to Friend virus. J Virol 67, 4163.
17. LIMJOCO T.I., NIHRANE A. & SILVER J. (1995) Resistance to retroviral infection in transgenic and bone marrow chimeric mice containing Fv-4 env expressing hematopoietic cells. Virololy 208, 85.
18. KITAGAWA M., KAMISAKU H., AIZAWA S. & SATO R. (1994) Bone marrow transplantation from Fv-4 resistant donors rescues Friend leukemia virus infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection. Leukemia 8, 2200.
19. CRISE B., BUONOCORE L. & ROSE J.K. (1990) CD4 is retained in the endoplasmic reticulum by the Human Immunodeficiency Virus type I glycoprotein precursor. J Virol 64, 5585.
20. KITAGAWA K., AIZAWA S., KAMISAKU H., IKEDA H., HIROKAWA H. & SATO T. (1995) Cell-free Friend leukemia virus induced leukemogenesis: a unique mechanism for interference with viral infection. Blood 86, 1557.
21. NIHRANE A., FUJITA K., WILLEY R., LYU M.S. & SILVER J. (1996) Murine leukemia virus envelope protein in serum of transgenic mice that blocks infection in vitro. J Virol 70, 1882.
22. MORRISON R.P., NISHIO J. & CHESEBRO B. (1986) Influence of the murine MHC (H2) on Friend Leukemia Virus-induced immunosuppression. J Exp Med 163, 301.
23. DAI H.Y., FAXVAAG, A., TROSETH G.I., AARSET H. & DALEN A. (1994) Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend Murine Leukemia virus, FIS-2. J Virol 68, 6976.
24. CLEMENTS J.E., WALL R.J., NARAYAN O. et al. (1994) Development of transgenic sheep that express the Visna Virus envelope gene. Virology 200, 370.
25. b mutant bm 13 mice. J Virol 68, 6038.
26. b restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus AKR623 that restores susceptibility of a tumor line to anti-AKR Gross MuLV cytotoxic T lymphocytes. J Virol 68, 897.
27. RUAN K.S. & LILLY F. (1991) Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T lymphocytes Virology 181, 91.
28. CHESEBRO B., WEHRLY K. & PORTIS J. (1976) Characterization of Ia8 antigen, Thy 1.2 antigen, complement receptor and virus production in a group of murine virus-induced leukemia cell lines. J Immunol 117, 1267.
29. COLLINS J.K. & CHESEBRO B. (1980) Spontaneous cessation of virus production by a Friend virus leukemia cell line: overgrowth by nonproducer cell clones. J Natl Cancer Inst 64, 1153.
30. MOORE M.W., CARBONE F.R. & BEVAN M.J. (1988) Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777.
31. ODAKA T., IKEDA H., YOSHIKURA H., MORIWAKI K. & SUZUKI S. (1981) Fv-4: gene controlling resistance to NB-tropic Friend murine leukemia virus. Distribution in wild mice, introduction into genetic background of Balb/c mice, and mapping of chromosomes. J Natl Cancer Inst 67, 1123.
32. CHESEBRO B., CLOYD L., BRITT W., PORTIS J., COLLINS J. & NISHIO J. (1981) Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus induced erythroleukemia cells: Friend-specific and FMR specific antigens. Virology 112, 131.
33. EVANS L., MORRISON R.P., MALIK F.G., PORTIS J. & BRITT W. (1990) A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic and amphotropic murine leukemia viruses. J Virol 64, 6176.
34. BUBBERS J.E. & HENNY C.S. (1975) Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells. J Immunol 114, 1126.
35. SCHIRMBECK R., BOHM W. & REIMANN J. (1994) Injection of detergent-denatured ovalbumin primes murine class I restricted cytotoxic T cells in viro. Eur J Immunol 24, 2068.
36. KAI K., SATO H. & ODAKA T. (1986) Relationship between the cellular resistance to Friend murine leukemia virus infection and the expression of murine leukemia virus-gp-70 related glycoprotein on cell surface of BALB/c-Fv-4wr mice. Virology 150, 509.
37. SHINNICK T.M., LEARNER R.A. & SUTCLIFFE J.G. (1981) Nucleotide sequence of Moloney murine leukemia virus. Nature 293, 543.
38. ABRAMCZUK J.W., KEARNS-JONKER M., MONELL-TORRENS E., WOHLENBERG C. & NOTKINS A. (1991) Transgenic mouse lines that are immunologically tolerant and nontolerant to Herpes Simplex Virus glycoprotein D. J Virol 65, 6124.
39. RAMSDELL F. & FOWLKES B.J. (1990) Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 248, 1342.
40. BURTLES S., TREMBLEAU S., DREXLER K. & HURTENBACH U. (1992) Absence of T cell tolerance to pancreatic islet cells. J Immunol 149, 2185.
41. OLDSTONE M.B., NERENBERG M., SOUTHERN P., PRICE J. & LEWICKI H. (1991) Virus infection triggers insulin dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65, 319.
42. HARLAN D.M., HENGARTNER H., HUANG M.L. et al. (1994) Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc Natl Acad Sci USA 91, 3137.
43. VON HERRATH M.G., DOCKLER J. & OLDSTONE M.B. (1994) How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1, 231.
44. OHASHI P.S., OEHEN S., BUERKI K. et al. (1992) Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305.
45. SCOTT B., LIBLAU R., DEGERMANN S. et al. (1994) A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1, 73.
46. BACHMANN M.F., ROHRER U.H., KÜNDIG T.M., BÜRKI K., HERNGARTNER H. & ZINKERNAGHL R.M. (1993) The influence of antigen organization on B cell responsiveness. Science 262, 1448.
47. CHILLER J.M., HABICHT G.S. & WEIGLE W.O. (1971) Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science 171, 813.
48. DRESSER D.W. (1961) Effectiveness of lipid and lipidophilic substances as adjuvants. Nature 191, 1169.
49. KEARNEY E.R., PAPE K.A., LOH D.Y. & JENKINS M.A. (1994) Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327.